HAVCR1 and cancer: Furthermore, Kaplan–Meier analysis demonstrated that HAVCR1 significantly distinguished kidney cancer patients from non-cancer individuals within the overall population (P < 0.001) (Supplemental Digital Content, Figure S7a, available at: http://links.lww.com/JS9/F76).